6797-47-3

Usage

Group

Oxime derivatives

Physical State

Yellow solid

Molecular Weight

181.19 g/mol

Uses

a. Organic synthesis
b. Reagent in various chemical reactions

Potential Applications

a. Pharmaceutical industry
b. Agrochemical industry

Biological Activities

a. Antioxidant properties
b. Anti-inflammatory properties

Research Status

Further research needed to fully understand potential uses and effects

Downstream Products

• 6796-61-8 (4-methoxy-phenyl)-(2-p-tolyl-thiazol-4-yl)-ethanedione 2-oxime 
• 6796-69-6 (4-methoxy-phenyl)-[2-(4-methoxy-phenyl)-thiazol-4-yl]-ethanedione 2-oxime 
• 6796-55-0 (4-methoxy-phenyl)-(2-phenyl-thiazol-4-yl)-ethanedione 2-oxime 
• 6796-65-2 [2-(4-chloro-phenyl)-thiazol-4-yl]-(4-methoxy-phenyl)-ethanedione 1-oxime 

Relevant academic research and scientific papers

Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders

Compounds of the formula I are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases whose course involves an increased activity of NIK.

PYRAZOLOISOQUINOLINE DERIVATIVES AS KINASE INHIBITORS

Novel pyrazoloisoquinoline derivatives as kinase inhibitors are disclosed which are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases whose course involves an increased activity of NIK.

PYRAZOLOISOQUINOLINE DERIVATIVES FOR INHIBITING NFKAPPAB-INDUCING KINASE (NIK)

The invention relates to compounds of formula (I), which are suitable for producing medicaments for the prophylaxis and treatment of diseases, the progression of which involves an increased activity of NIK.